Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Yang Website

Howard H. Yang, Ph.D.

Selected Publications

1)  Sato M, Kadota M, Tang B, Yang HH, Yang YA, Shan M, Weng J, Welsh MA, Flanders KC, Nagano Y, Michalowski AM, Clifford RJ, Lee MP, Wakefield LM.
An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-beta in human breast cancer.
Breast Cancer Res. 16: R57, 2014.
[Journal]
2)  Wang G, Hu N, Yang HH, Wang L, Su H, Wang C, Clifford R, Dawsey EM, Li JM, Ding T, Han XY, Giffen C, Goldstein AM, Taylor PR, Lee MP.
Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in china.
PLoS ONE. 8: e63826, 2013.
[Journal]
3)  Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, Baek S, Hunter K, Yang H, Lee M, Zvosec C, Khramtsova G, Cheng F, Perou CM, Miller CR, Raab R, Olopade OI, Gardner K.
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.
Nat Commun. 4: 1449, 2013.
[Journal]
4)  Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR.
Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes.
Clin. Cancer Res. 17: 2955-66, 2011.
[Journal]
5)  Yang HH, Hu N, Wang C, Ding T, Dunn BK, Goldstein AM, Taylor PR, Lee MP.
Influence of genetic background and tissue types on global DNA methylation patterns.
PLoS ONE. 5: e9355, 2010.
[Journal]
6)  Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP.
Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
PLoS ONE. 5: e9201, 2010.
[Journal]
7)  Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T, Taylor PR, Lee MP.
Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
BMC Genomics. 11: 576, 2010.
[Journal]
8)  Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, Wang QH, Han XY, Giffen C, Goldstein AM, Taylor PR, Lee MP.
Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China.
Cancer Res. 69: 5908-17, 2009.
[Journal]
9)  Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, Fukuoka J, Nagata T, Tsukada K, Dunn BK, Wakefield LM, Lee MP.
Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.
Cancer Res. 69: 7357-65, 2009.
[Journal]
10)  Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW.
Bromodomain 4 activation predicts breast cancer survival.
Proc. Natl. Acad. Sci. U.S.A. 105: 6380-5, 2008.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 7/14/2014.